DNA-binding	O
and	O
transcriptional	O
regulatory	O
properties	O
of	O
hepatic	B-protein
leukemia	I-protein
factor	I-protein
(	O
HLF	B-protein
)	O
and	O
the	O
t	O
(	O
17	O
;	O
19	O
)	O
acute	B-protein
lymphoblastic	I-protein
leukemia	I-protein
chimera	I-protein
E2A-HLF	I-protein
.	O

The	O
t	B-DNA
(	I-DNA
17	I-DNA
;	I-DNA
19	I-DNA
)	I-DNA
translocation	O
in	O
acute	O
lymphoblastic	O
leukemias	O
results	O
in	O
creation	O
of	O
E2A-hepatic	B-protein
leukemia	I-protein
factor	I-protein
(	O
HLF	B-protein
)	O
chimeric	B-protein
proteins	I-protein
that	O
contain	O
the	O
DNA-binding	B-protein
and	I-protein
protein	I-protein
dimerization	I-protein
domains	I-protein
of	O
the	O
basic	B-protein
leucine	I-protein
zipper	I-protein
(	I-protein
bZIP	I-protein
)	I-protein
protein	I-protein
HLF	B-protein
fused	O
to	O
a	O
portion	O
of	O
E2A	B-protein
proteins	I-protein
with	O
transcriptional	O
activation	O
properties	O
.	O

An	O
in	O
vitro	O
binding	O
site	O
selection	O
procedure	O
was	O
used	O
to	O
determine	O
DNA	O
sequences	O
preferentially	O
bound	O
by	O
wild-type	B-protein
HLF	I-protein
and	O
chimeric	B-protein
E2A-HLF	I-protein
proteins	O
isolated	O
from	O
various	O
t	B-cell_line
(	I-cell_line
17	I-cell_line
;	I-cell_line
19	I-cell_line
)	I-cell_line
-bearing	I-cell_line
leukemias	I-cell_line
.	O

All	O
were	O
found	O
to	O
selectively	O
bind	O
the	O
consensus	B-DNA
sequence	I-DNA
5'-GTTACGTAAT-3	O
'	O
with	O
high	O
affinity	O
.	O

Wild-type	O
and	O
chimeric	B-protein
HLF	I-protein
proteins	I-protein
also	O
bound	O
closely	O
related	O
sites	O
identified	O
previously	O
for	O
bZIP	B-protein
proteins	I-protein
of	O
both	O
the	O
proline	B-protein
-and	O
acidic	O
amino	O
acid-rich	O
(	O
PAR	B-protein
)	O
and	O
C/EBP	B-protein
subfamilies	I-protein
;	O
however	O
,	O
E2A-HLF	B-protein
proteins	O
were	O
significantly	O
less	O
tolerant	O
of	O
certain	O
deviations	O
from	O
the	O
HLF	B-DNA
consensus	I-DNA
binding	I-DNA
site	I-DNA
.	O

These	O
differences	O
were	O
directly	O
attributable	O
to	O
loss	O
of	O
an	O
HLF	B-DNA
ancillary	I-DNA
DNA-binding	I-DNA
domain	I-DNA
in	O
all	O
E2A-HLF	B-protein
chimeras	I-protein
and	O
were	O
further	O
exacerbated	O
by	O
a	O
zipper	O
mutation	O
in	O
one	O
isolate	O
.	O

Both	O
wild-type	B-protein
and	O
chimeric	B-protein
HLF	I-protein
proteins	I-protein
displayed	O
transcriptional	B-protein
activator	I-protein
properties	O
in	O
lymphoid	B-cell_type
and	I-cell_type
nonlymphoid	I-cell_type
cells	I-cell_type
on	O
reporter	B-DNA
genes	I-DNA
containing	O
HLF	B-DNA
or	I-DNA
C/EBP	I-DNA
consensus	I-DNA
binding	I-DNA
sites	I-DNA
.	O

But	O
on	O
reporter	B-DNA
genes	I-DNA
with	O
nonoptimal	B-DNA
binding	I-DNA
sites	I-DNA
,	O
their	O
transcriptional	O
properties	O
diverged	O
and	O
E2A-HLF	B-protein
competitively	O
inhibited	O
activation	O
by	O
wild-type	B-protein
PAR	I-protein
proteins	I-protein
.	O

These	O
findings	O
establish	O
a	O
spectrum	O
of	O
binding	O
site-specific	O
transcriptional	O
properties	O
for	O
E2A-HLF	B-protein
which	O
may	O
preferentially	O
activate	O
expression	O
of	O
select	O
subordinate	O
genes	O
as	O
a	O
homodimer	O
and	O
potentially	O
antagonize	O
expression	O
of	O
others	O
through	O
heteromeric	O
interactions	O
.	O

